Related Experiment Video
Updated: Jan 7, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Silence of circPLK1 inhibits NSCLC progression by regulating the miR-1294/SLC16A9 axis
Chuankui Li1, Yifan Yang1, Qicai Li1
1Department of Thoracic Surgery, the First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233000, PR China.
Background:
Non-small cell lung cancer (NSCLC) is the malignancy with the highest mortality worldwide. Circular RNA polo-like kinase 1 (circPLK1) is a circular RNA that involved in cancer progression. However, the role of circPLK1 in NSCLC requires further investigation.
Methods:
The expression of circPLK1 in NSCLC cells was measured by using qRT-PCR. Bioinformatics analysis was performed to identify miRNAs that bind to circPLK1 and the target mRNAs of these miRNAs. Cell viability, proliferation, apoptosis, migration, and invasion were assessed using CCK-8, colony formation, flow cytometry, and Transwell assays, respectively. Protein expression was evaluated by western blotting. Xenograft models were established to verify the regulatory role of circPLK1 in the miR-1294/SLC16A9 axis.
Results:
circPLK1 was upregulaterd in NSCLC cells. Silencing circPLK1 markedly inhibited cell viability, proliferation, migration, and invasion, while accelerating apoptosis in NSCLC cells. circPLK1 acted as a sponge for miR-1294 and promoted SLC16A9 expression in NSCLC cells. Knockdown of circPLK1 suppressed tumor growth in NSCLC by regulating the miR-1294/SLC16A9 axis.
Conclusion:
circPLK1 silence inhibited the proliferation, migration, and invasion of NSCLC cells by regulating the miR-1294/SLC16A9 axis.
Insights
Circular RNA polo-like kinase 1 (circPLK1) promotes non-small cell lung cancer (NSCLC) progression. Silencing circPLK1 inhibits NSCLC cell proliferation, migration, and invasion via the miR-1294/SLC16A9 pathway.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality globally.
- Circular RNAs (circRNAs) are implicated in cancer progression, but their specific roles require elucidation.
- The function of circRNA polo-like kinase 1 (circPLK1) in NSCLC pathogenesis is not well understood.
Purpose of the Study:
- To investigate the role and mechanism of circPLK1 in non-small cell lung cancer (NSCLC).
- To determine the regulatory relationship between circPLK1, miR-1294, and SLC16A9 in NSCLC.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to measure circPLK1 expression.
- Bioinformatics analysis to predict miRNA-target interactions.
- Cellular assays (CCK-8, colony formation, flow cytometry, Transwell) to assess proliferation, viability, apoptosis, migration, and invasion.
- Western blotting for protein analysis and xenograft models for in vivo validation.
Main Results:
- circPLK1 expression was significantly upregulated in NSCLC cells.
- Silencing circPLK1 inhibited NSCLC cell viability, proliferation, migration, and invasion, while promoting apoptosis.
- circPLK1 functions as a molecular sponge for miR-1294, enhancing SLC16A9 expression.
- Knockdown of circPLK1 suppressed tumor growth in vivo by modulating the miR-1294/SLC16A9 axis.
Conclusions:
- circPLK1 plays a crucial role in promoting NSCLC progression.
- circPLK1 inhibition suppresses NSCLC proliferation, migration, and invasion through the miR-1294/SLC16A9 pathway.
- circPLK1 represents a potential therapeutic target for NSCLC treatment.
Related Concept Videos
Inhibition of Cdk Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
MicroRNAs
MicroRNAs

